Alexandra Simbrich
Muenster, NW 48149, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Self-perceived versus physician documented adverse events in patients with multiple sclerosis REGIMS-a pharmacovigilance registry for patients with multiple sclerosis in Germany.
Journal: Multiple sclerosis and related disorders
Published: July 02, 2021
Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial.
Journal: Scientific reports
Published: April 12, 2021
Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry.
Journal: Drug safety
Published: September 27, 2020
Management of MS Patients Treated With Daclizumab - a Case Series of 267 Patients.
Journal: Frontiers in neurology
Published: April 17, 2020
Drug-use patterns and severe adverse events with disease-modifying drugs in patients with multiple sclerosis: a cohort study based on German claims data.
Journal: Neuropsychiatric disease and treatment
Published: January 09, 2019
Development and Prospective Randomized Evaluation of a Decision Aid for Prostate-specific Antigen-based Early Detection of Prostate Cancer in Men Aged Between 55 and 69Yr: The PSAInForm Trial.
Journal: European urology
Published: December 20, 2018
Practice of early detection of prostate cancer : Descriptive survey in preparation for the PSAInForm study
Journal: Der Urologe. Ausg. A
Published: April 20, 2018
Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population.
Journal: Cancer epidemiology
Published: May 05, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026